V017-8939 Screening compound: 2-[4-(morpholin-4-yl)-2-(pyrrolidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carbonyl]quinoxaline

V017-8939 Screening compound: 2-[4-(morpholin-4-yl)-2-(pyrrolidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carbonyl]quinoxaline
V017-8939 Screening compound: 2-[4-(morpholin-4-yl)-2-(pyrrolidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carbonyl]quinoxaline alternative view

Chemical Structure Depiction of ChemDiv screening compound V017-8939
2-[4-(morpholin-4-yl)-2-(pyrrolidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carbonyl]quinoxaline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V017-8939

Molecular Formula

C24H27N7O2 (C24 H27 N7 O2)

Compound Name

2-[4-(morpholin-4-yl)-2-(pyrrolidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carbonyl]quinoxaline

IUPAC name

2-[4-(morpholin-4-yl)-2-(pyrrolidin-1-yl)-5H6H7H8H-pyrido[43-d]pyrimidine-6-carbonyl]quinoxaline

SMILES

O=C(c1nc2ccccc2nc1)N1Cc2c(N3CCOCC3)nc(N3CCCC3)nc2CC1

InChI

InChI=1S/C24H27N7O2/c32-23(21-15-25-19-5-1-2-6-20(19)26-21)31-10-7-18-17(16-31)22(29-11-13-33-14-12-29)28-24(27-18)30-8-3-4-9-30/h1-2,5-6,15H,3-4,7-14,16H2

InChI Key

QJLPYWZZULXEIL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19933051

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

445.52

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.189

Distribution Coefficient, logD

3.188

Water Solubility, LogSw

-3.05

Polar Surface Area

68.115

Acid Dissociation Constant (pKa)

19.71

Base Dissociation Constant (pKb)

11.30

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.80

V017-8939 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with V017-8939 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V017-8939?
Check Price and Availability of V017-8939, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V017-8939 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V017-8939
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V017-8939
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V017-8939 available by request